TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 12 | 1 | -1 | 3 | 33 | 132 | 30 |
| S | %wins | 0 | 50 | 50 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/17/12 18:35 | 10/15/12 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners III LP | CA | T | S.m | -3,679 | 18.33 | 7 | -201 | -8 | 2,336 | M | 39 | 59 | 27 | 31 | 29 | 37 | 37 | 9 | 7 | 6 | 45 | 110 | 323 | ||
12/16/09 17:17 | 12/14/09 | SNSS | Sunesis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners III LP | CA | T | S | -4,486 | 2.01 | 0 | -2,232 | -100 | 0 | M | -13 | 280 | 317 | 272 | 386 | 465 | 317 | 26 | 15 | -5 | -8 | -39 | -45 | -59 | |
10/18/05 13:16 | 10/14/05 | CTRX | Cotherix Inc | Health | BioPrd | Biological Products, (No Diag | Alta Biopharma Partners III LP | CA | T | S | -2,170 | 13.00 | 0 | -167 | -7 | 2,385 | I | ||||||||||||||||
10/14/05 16:23 | 10/12/05 | CTRX | Cotherix Inc | Health | BioPrd | Biological Products, (No Diag | Alta Biopharma Partners III LP | CA | T | S | -3,215 | 13.00 | 0 | -247 | -9 | 2,388 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |